DXR Share Price

Open 6.01 Change Price %
High 6.07 1 Day -0.20 -3.19
Low 6.00 1 Week -0.17 -2.72
Close 6.07 1 Month -0.18 -2.88
Volume 2900 1 Year -2.01 -24.88
52 Week High 9.80
52 Week Low 0.00
DXR Important Levels
Resistance 2 6.13
Resistance 1 6.11
Pivot 6.05
Support 1 6.03
Support 2 6.01
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
BTI 69.85 1.67%
BTI 69.85 1.67%
RBY 0.03 -70.00%
NGD 3.09 -2.52%
NGD 3.09 -2.52%
PBTH 8.23 0.37%
GGR 0.02 100.00%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
CUR 1.75 -29.15%
CUR 1.75 -29.15%
CUR 1.75 -29.15%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
More..

Daxor Corporation (AMEX: DXR)

DXR Technical Analysis 5
As on 27th Jul 2017 DXR Share Price closed @ 6.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.81 & Strong Sell for SHORT-TERM with Stoploss of 6.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
DXR Target for July
1st Target up-side 10.04
2nd Target up-side 12.73
3rd Target up-side 15.42
1st Target down-side 2.36
2nd Target down-side -0.33
3rd Target down-side -3.02
DXR Other Details
Segment EQ
Market Capital 33775400.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.daxor.com
DXR Address
DXR
Empire State Building
350 Fifth Avenue
New York, NY 10118
United States
Phone: 212-244-0555
Fax: 212-244-0806
DXR Latest News
Chart Update on These Shares: Daxor Corp (DXR)   Midway Monitor   - 27th Jul 17
Is There Strength Behind the Numbers For Daxor Corporation (AMEX:DXR)   Financial Newsweek   - 27th Jul 17
Daxor Corp (DXR) AO Signal Intensifying Over Past 5 Bars   Evergreen Caller   - 27th Jul 17
Daxor Corporation Holds Annual Meeting, Provides Business Growth Update and ...   Marketwired (press release)   - 30th Jun 17
Daxor Corporation Announces Hiring of Chief Financial Officer   Marketwired (press release)   - 31st May 17
Daxor Corporation Announces Death of Founder, Chief Medical Officer, and ...   Marketwired (press release)   - 02nd Feb 17
Daxor Corporation Announces Dividend, Patent Approval, Title Change   Marketwired (press release)   - 19th Nov 16
Daxor Corporation Announces Filing of Form N-CSR for June 30, 2016   Marketwired (press release)   - 15th Sep 16
Daxor Corp. (DXR) Names New CFO   StreetInsider.com   - 17th Jun 16
6.05   MarketWatch   - 10th Oct 10
Interactive Technical Analysis Chart Daxor Corporation ( DXR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Daxor Corporation
DXR Business Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.